General Information
Version
6.5
Revision date
2023-11-02
Product name
Riluzole Related Compound A, United States Pharmacopeia (USP) Reference Standard
CAS No.
461-82-5
REACH No
A
Icons in SDS
Company Information
company name
Merck Life Science (Pty) Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
Melissa.byrne@merckgroup.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H310, H315, H318, H373
Hazard statements
Code
Statements
H310
Fatal in contact with skin
H315
Causes skin irritation
H318
Causes serious eye damage.
H373
May cause damage to organs through prolonged or repeated exposure
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008] Classification of the substance or mixture
Signal word
Danger
Hazard statements
H301 Toxic if swallowed. H310 Fatal in contact with skin. H315 Causes skin irritation. H318 Causes serious eye damage. H373 May cause damage to organs through prolonged or repeated exposure.
Precautionary statements
P260 Do not breathe dust/ fume/ gas/ mist/ vapors/ spray. P280 Wear eye protection/ face protection. P280 Wear protective gloves/ protective clothing. P301 + P330 + P331 + IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. P310 Immediately call a POISON CENTER/ doctor. P302 + P352 + P310 IF ON SKIN: Wash with plenty of water. Immediately call a POISON CENTER/ doctor. P305 + P351 + P338 + IF IN EYES: Rinse cautiously with water for several minutes. P310 Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER/ doctor.
Supplemental label elements
none
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 Acute toxicity, Oral (Category 3), H301 Acute toxicity, Dermal (Category 2), H310 Skin irritation (Category 2), H315 Serious eye damage (Category 1), H318 Specific target organ toxicity - repeated exposure (Category 2), H373 For the full text of the H-Statements mentioned in this Section, see Section 16.
